| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215806 Rosuvastatin calcium with a low salt content |
| 08/27/2009 | US20090215805 4-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase Inhibitors |
| 08/27/2009 | US20090215801 Novel 2-Aminopyrimidinone Derivatives And Their Use |
| 08/27/2009 | US20090215777 Pyrimidine Derivatives As HSP90 Inhibitors |
| 08/27/2009 | US20090215765 Neuroprotective compounds for treating optic neuropathies |
| 08/27/2009 | US20090215730 Antineoplastic compounds and pharmaceutical compositions thereof |
| 08/27/2009 | US20090214529 Kinesin inhibitors |
| 08/27/2009 | US20090214465 Quinoxaline Derivatives as Antitumor Agents |
| 08/27/2009 | CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase |
| 08/26/2009 | EP2091941A2 Mapk/erk kinase inhibitors |
| 08/26/2009 | EP2091925A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 08/26/2009 | EP2091924A1 Pyrimidine derivatives and their use as pesticides |
| 08/26/2009 | EP2091923A1 Process for the preparation of rosuvastatin |
| 08/26/2009 | EP2091918A2 Compounds and compositions as protein kinase inhibitors |
| 08/26/2009 | EP1745033A4 4,5-disubstituted-2-aryl pyrimidines |
| 08/26/2009 | EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1298115B1 Process for the preparation of polyhydric alcohols |
| 08/26/2009 | EP1242386B1 Nitro-sulfobenzamides |
| 08/26/2009 | CN201295609Y Reaction kettle for producing trimethoprim and midbody benzaldehyde dibromide thereof |
| 08/26/2009 | CN101516858A Crystalline antifungal compounds |
| 08/26/2009 | CN101516857A Labelling of fusion proteins with synthetic probes |
| 08/26/2009 | CN101516850A Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 08/26/2009 | CN101516834A Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 08/26/2009 | CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 08/26/2009 | CN101514190A Method for preparing heterocyclic compounds of methyl mercapto under ionic liquid catalysis |
| 08/25/2009 | US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/25/2009 | US7579466 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579356 Thia-tetraazaacenaphthylene kinase inhibitors |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | CA2474578C Novel pyridin- and pyrimidin-derivatives |
| 08/25/2009 | CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/20/2009 | WO2009100536A1 Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures |
| 08/20/2009 | WO2009025876A3 Crystalline forms of erlotinib hcl and formulations thereof |
| 08/20/2009 | WO2009025873A3 Processes for the preparation of crystalline forms a, b and pure crystalline form a of erlotinib hcl |
| 08/20/2009 | US20090209758 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 08/20/2009 | US20090209567 Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
| 08/20/2009 | US20090209564 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds And Methods Of Use |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209536 Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| 08/20/2009 | US20090209519 Pyrimidine compound and pests controlling composition containing the same |
| 08/20/2009 | US20090209518 Pyrimidine compound and pests controlling composition containing the same |
| 08/20/2009 | US20090206326 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 08/20/2009 | CA2714087A1 Inhibitors of checkpoint kinases |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2089385A2 Inhibitors of hepatitis c virus |
| 08/19/2009 | EP2089369A2 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 08/19/2009 | EP2089356A1 Salt of aliskiren with orotic acid |
| 08/19/2009 | EP2089355A2 Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof |
| 08/19/2009 | EP1838304B1 Heterocyclic aspartyl protease inhibitors |
| 08/19/2009 | EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/19/2009 | EP1546119B1 Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 08/19/2009 | EP1513802B1 Alpha-sulfonylamino-acetonitriles |
| 08/19/2009 | EP1470114B1 Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 08/19/2009 | CN101511798A [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 08/19/2009 | CN101511791A Piperazinyl derivatives useful in the treatment of GPR38 receptor mediated diseases |
| 08/19/2009 | CN101511190A Pressure sensor fault detection |
| 08/19/2009 | CN101508678A Process for preparing 2-methyl-4-amino-5-acetyl aminomethyl pyrimidine |
| 08/19/2009 | CN100528763C Oxygen scavenger and boiler water treatment chemical |
| 08/19/2009 | CN100528762C Oxygen scavenger and boiler water treatment chemical |
| 08/19/2009 | CN100528264C Health gauze mask |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576127 Aromatic prodrugs of propofol, compositions and uses thereof |
| 08/18/2009 | US7576092 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 08/18/2009 | US7576091 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 08/18/2009 | US7576090 Benzazole analogues and uses thereof |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/13/2009 | WO2009100403A1 Substituted aryl pyrimidinones |
| 08/13/2009 | WO2009099929A1 Mesoionic pesticides |
| 08/13/2009 | WO2009098517A1 Process for preparing bosentan |
| 08/13/2009 | WO2009097709A1 Pyrazolopyrimidinone-containing phenyl guanidine derivatives, pharmaceutical compositions containing them, process for their preparation and their use |
| 08/13/2009 | WO2009097682A1 Anti-influenza compounds |
| 08/13/2009 | WO2009030224A3 Novel quinazoline compounds and the use thereof for treating cancerous diseases |
| 08/13/2009 | WO2009020683A3 Quinazoline compounds |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203905 Chemical process |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | US20090203674 Pyrimidine compound and pests controlling composition containing the same |
| 08/13/2009 | US20090203647 5-fluoro pyrimidine derivatives |
| 08/13/2009 | US20090203636 Prevention and Treatment of Cancer and Other Diseases |
| 08/13/2009 | CA2713848A1 Anti-influenza compounds |
| 08/13/2009 | CA2713347A1 Mesoionic pesticides |
| 08/13/2009 | CA2712860A1 Process for preparing bosentan |
| 08/12/2009 | EP2088142A2 Compounds and Processes |
| 08/12/2009 | EP2088141A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| 08/12/2009 | EP2086967A2 Inhibitors of hepatitis c virus |